Experimental Drug Slows Alzheimer's But Can It Make a Real Difference? | Chicago News

Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better treatments of the incurable disease.

Related Keywords

United States ,Japan ,San Francisco ,California ,Japanese ,Americans ,Ron Petersen ,Maria Carrillo ,Mayo Petersen ,Madhav Thambisetty ,Michael Irizarry ,National Institute On ,Alzheimer Association ,Drug Administration ,Christopher Van Dyck At Yale University ,Associated Press ,National Institute ,National Institutes ,New England Journal ,Mayo Clinic ,Health Care ,Study ,Alzheimer 039s Disease ,